NLNancy T. Li

Nancy T. Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nancy T. Li has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    React-to-Me: A Conversational Interface for Interactive Exploration of the Reactome Pathway Knowledgebase.

    by Helia Mohammadi, Fatemeh Almodaresi, Gregory Hogue, Adam Wright, Marija Orlic-Milacic, Nancy Li, Amin Mawani, Lincoln D Stein

    The Reactome Pathway Knowledgebase (www.reactome.org) provides expert-curated information on human biological pathways, molecular interactions, and disease mechanisms. However, its complex data model and keyword-based search interface present accessibility barriers for non-expert users. In contrast, general-purpose conversational AI systems offer intuitive natural language interfaces but lack the domain-specificity, transparent sourcing, and factual reliability required for scientific applications. To address this gap, we developed React-to-Me (https://reactome.org/chat), a domain-specific conversational assistant that enables users to query Reactome using natural language while maintaining scientific rigor and source traceability. React-to-Me integrates hybrid retrieval-augmented generation (RAG) with constrained language model generation to ensure that all responses are grounded in curated Reactome content and directly linked to corresponding knowledgebase entries. When internal coverage is insufficient, the system defers to trusted external biomedical sources rather than generating speculative or unverified content. Computational benchmarking confirmed that combining semantic vector search with keyword-based matching substantially improved contextual grounding and factual precision relative to dense-only retrieval baselines. In blinded expert evaluations, grounded responses were more likely to receive higher quality ratings than ungrounded counterparts, with significant gains in factual accuracy, biological specificity, and mechanistic depth. User surveys further indicated strong satisfaction with ease of use, citation reliability, and factual accuracy. These findings demonstrate that domain-specific grounding can markedly improve the reliability and usability of conversational AI for biological knowledge exploration. React-to-Me provides a transparent and scientifically robust interface for accessing and exploring Reactome content and is freely available at https://reactome.org/chat.


  • Lateral Assessment of Mucomimetic Hydrogels to Evaluate Correlation between Microscopic and Macroscopic Properties

    by Kristina L. Faurschou, Aaron J. Clasky, Jeffrey Watchorn, Jennifer Tram Su, Nancy T. Li, Alison P. McGuigan, Frank X. Gu

    A major limitation in the development of mucosal drug delivery systems is the design of in vitro models that accurately reflect in vivo conditions. Traditionally, models seek to mimic characteristics of physiological mucus, often focusing on property‐specific trial metrics such as rheological behavior or diffusion of a nanoparticle of interest. Despite the success of these models, translation from in vitro results to in vivo trials is limited. As a result, several authors have called for work to develop standardized testing methodologies and characterize the influence of model properties on drug delivery performance. To this end, a series of trials is performed on 12 mucomimetic hydrogels reproduced from literature. Experiments show that there is no consistent correlation between barrier performance and rheological or microstructural properties of the tested mucomimetic hydrogels. In addition, the permeability of both mucopenetrating and mucoadhesive nanoparticles is assessed, revealing non‐obvious variations in barrier properties such as the relative contributions of electrostatic and hydrophobic interactions in different models. These results demonstrate the limitations of predicting mucomimetic behavior with common characterization techniques and highlight the importance of testing barrier performance with multiple nanoparticle formulations.


  • Open Access

    A Cryopreservation Strategy for Myoblast Storage in Paper‐Based Scaffolds for Inter‐Laboratory Studies of Skeletal Muscle Health

    by Saifedine T. Rjaibi, Erik Jacques, Jiaru Ni, Bin Xu, Sonya Kouthouridis, Julie Sitolle, Heta Lad, Nitya Gulati, Nancy T. Li, Henry Ahn, et al.

    3D tissue‐engineered models are poised to facilitate understanding of skeletal muscle pathophysiology and identify novel therapeutic agents to improve muscle health. Adopting these culture models within the broader biology community is a challenge as many models involve complex methodologies and significant investments of time and resources to optimize manufacturing protocols. To alleviate this barrier, a protocol with commercially available reagents is developed to cryopreserve myoblasts in a 96‐well compatible format that allows tissues to be transferred to users without expertise in 2D or 3D skeletal muscle cell culture. This report validates that myoblasts encapsulated in a hydrogel and cryopreserved in paper‐based scaffolds maintain cell viability, differentiation, and function via acetylcholine‐induced transient calcium responses. Furthermore, successful shipping of myoblasts cryopreserved in paper‐based scaffolds to intra‐provincial and international collaborators is demonstrated who successfully thaw, culture, and use the 3D muscle tissues. Finally, the application of this method is confirmed for studying muscle endogenous repair by seeding freshly isolated skeletal muscle stem cells to cryopreserved then differentiated and injured tissues, demonstrating expected responses to a known stimulator of muscle stem cell self‐renewal, p38α/β MAPKi. Altogether, the 3D myoblast cryopreservation protocol offers broadened access of a complex skeletal muscle tissue model to the research community.


  • Bridging systems biology and tissue engineering: Unleashing the full potential of complex 3D in vitro tissue models of disease

    by Jose L. Cadavid, Nancy T. Li, Alison P. McGuigan

    Rapid advances in tissue engineering have resulted in more complex and physiologically relevant 3D in vitro tissue models with applications in fundamental biology and therapeutic development. However, the complexity provided by these models is often not leveraged fully due to the reductionist methods used to analyze them. Computational and mathematical models developed in the field of systems biology can address this issue. Yet, traditional systems biology has been mostly applied to simpler in vitro models with little physiological relevance and limited cellular complexity. Therefore, integrating these two inherently interdisciplinary fields can result in new insights and move both disciplines forward. In this review, we provide a systematic overview of how systems biology has been integrated with 3D in vitro tissue models and discuss key application areas where the synergies between both fields have led to important advances with potential translational impact. We then outline key directions for future research and discuss a framework for further integration between fields.


  • Climate Crisis Induced Migration: A Global Framework to Minimize and Manage Large-Scale Climate Refugees and Migrants

    by Bipin Kumar Badri Narayanan, Megan L. Shipman, Liam Foyle, Kaitlin Kharas, Bryn Livingston, Nancy T. Li, Maria Victoria Medeleanu, Luna Taguchi

    The ongoing climate crisis will force the migration of up to 1.2 billion people by 2050. Since climate displacement has already begun, having policies in place to mitigate predictable issues that will arise from mass migration and safeguard vulnerable populations is essential. We recommend assigning a special “climate refugee/migrant” status to ensure human rights protections for these refugees/migrants. We also propose preventative measures to help reduce climate-related immigration and essential measures to facilitate refugees adapting to new regions. Finally, we recommend strategies to implement a “Loss and Damage” fund for the developing countries most vulnerable to climate-related disasters. These policies address a critical gap in climate migration policy and could inform the upcoming Conference of the Parties (COP 28) of the United Nations Framework Convention on Climate Change (UNFCCC) in Dubai in November 2023


  • Open Access

    An Automation Workflow for High‐Throughput Manufacturing and Analysis of Scaffold‐Supported 3D Tissue Arrays

    by Ruonan Cao, Nancy T. Li, Simon Latour, Jose L. Cadavid, Cassidy M. Tan, Ari Forman, Hartland W. Jackson, Alison P. McGuigan

    Patient‐derived organoids have emerged as a useful tool to model tumour heterogeneity. Scaling these complex culture models while enabling stratified analysis of different cellular sub‐populations, however, remains a challenge. One strategy to enable higher throughput organoid cultures is the scaffold‐supported platform for organoid‐based tissues (SPOT). SPOT allows the generation of flat, thin, and dimensionally‐defined microtissues in both 96‐ and 384‐well plate footprints that are compatible with longitudinal image‐based readouts. SPOT is currently manufactured manually, however, limiting scalability. In this study, an automation approach to engineer tumour‐mimetic 3D microtissues in SPOT using a liquid handler is optimized and comparable within‐ and between‐sample variation to standard manual manufacturing is shown. Further, a liquid handler‐supported cell extraction protocol to support single‐cell‐based end‐point analysis using high‐throughput flow cytometry and multiplexed cytometry by time of flight is developed. As a proof‐of‐value demonstration, 3D complex tissues containing different proportions of tumour and stromal cells are generated to probe the reciprocal impact of co‐culture. It is also demonstrated that primary patient‐derived organoids can be incorporated into the pipeline to capture patient‐level tumour heterogeneity. It is envisioned that this automated 96/384‐SPOT workflow will provide opportunities for future applications in high‐throughput screening for novel personalized therapeutic targets.


  • An off-the-shelf multi-well scaffold-supported platform for tumour organoid-based tissues

    by Nancy T. Li, Nila C. Wu, Ruonan Cao, Jose L. Cadavid, Simon Latour, Xiaoya Lu, Yutong Zhu, Mirjana Mijalkovic, Reza Roozitalab, Natalie Landon-Brace, et al.


  • Open Access

    An automation workflow for high-throughput manufacturing and analysis of scaffold-supported 3D tissue arrays

    by Ruonan Cao, Nancy T Li, Jose L Cadavid, Simon Latour, Cassidy M Tan, Alison P McGuigan

    The success rate of bringing novel cancer therapies to the clinic remains extremely low due to the lack of relevant pre-clinical culture models that capture the complexity of human tumours. Patient-derived organoids have emerged as a useful tool to model patient and tumour heterogeneity to begin addressing this need. Scaling these complex culture models while enabling stratified analysis of different cellular sub-populations remains a challenge, however. One strategy to enable higher throughput organoid cultures that also enables easy image-based analysis is the Scaffold-supported Platform for Organoid-based Tissues (SPOT) platform. SPOT allows the generation of flat, thin and dimensionally-defined microtissues in both 96- and 384-well plate footprints and is compatible with tumour organoid culture and downstream image-based readouts. SPOT manufacturing is currently a manual process however, limiting the use of SPOT to perform larger-scale screening. In this study, we integrate and optimize an automation approach to generate tumour-mimetic 3D engineered microtissues in SPOT using a liquid handler, and show comparable within-sample and between-sample variation as the standard manual manufacturing process. Furthermore, we develop a liquid handler-supported whole-cell extraction protocol and as a proof-of-value demonstration, we generate 3D complex tissues containing different proportions of tumour and stromal cells and perform single-cell-based end-point analysis to demonstrate the impact of co-culture on the tumour cell population specifically. We also demonstrate we can incorporate primary patient-derived organoids into the pipeline to capture patient-level tumour heterogeneity. We envision that this automated workflow integrated with 96/384-SPOT and multiple cell types and patient-derived organoid models will provide opportunities for future applications in high-throughput screening for novel personalized therapeutic targets. This pipeline also allows the user to assess dynamic cell responses using high-content longitudinal imaging or downstream single-cell-based analyses.


  • A three-dimensional human adipocyte model of fatty acid-induced obesity

    by Vera M Pieters, Saifedine T Rjaibi, Kanwaldeep Singh, Nancy T Li, Safwat T Khan, Sara S Nunes, Arianna Dal Cin, Penney M Gilbert, Alison P McGuigan

    Obesity prevalence has reached pandemic proportions, leaving individuals at high risk for the development of diseases such as cancer and type 2 diabetes. In obesity, to accommodate excess lipid storage, adipocytes become hypertrophic, which is associated with an increased pro-inflammatory cytokine secretion and dysfunction of metabolic processes such as insulin signaling and lipolysis. Targeting adipocyte dysfunction is an important strategy to prevent the development of obesity-associated disease. However, it is unclear how accurately animal models reflect human biology, and the long-term culture of human hypertrophic adipocytes in an in vitro 2D monolayer is challenging due to the buoyant nature of adipocytes. Here we describe the development of a human 3D in vitro disease model that recapitulates hallmarks of obese adipocyte dysfunction. First, primary human adipose-derived mesenchymal stromal cells are embedded in hydrogel, and infiltrated into a thin cellulose scaffold. The thin microtissue profile allows for efficient assembly and image-based analysis. After adipocyte differentiation, the scaffold is stimulated with oleic or palmitic acid to mimic caloric overload. Using functional assays, we demonstrated that this treatment induced important obese adipocyte characteristics such as a larger lipid droplet size, increased basal lipolysis, insulin resistance and a change in macrophage gene expression through adipocyte-conditioned media. This 3D disease model mimics physiologically relevant hallmarks of obese adipocytes, to enable investigations into the mechanisms by which dysfunctional adipocytes contribute to disease.


  • Open Access

    An off-the-shelf multi-well scaffold-supported platform for tumour organoid-based tissues

    by Nancy T Li, Nila C Wu, Ruonan Cao, Jose L Cadavid, Simon Latour, Xiaoya Lu, Yutong Zhu, Mirjana Mijalkovic, Reza Roozitalab, Alison P McGuigan

    Complex 3D bioengineered tumour models provide the opportunity to better capture the heterogeneity of patient tumours. Patient-derived organoids are emerging as a useful tool to study tumour heterogeneity and variation in patient responses. Organoid cultures typically require a 3D microenvironment that can be manufactured easily to facilitate screening. Here we set out to create a high-throughput, “off-the-shelf” platform which permits the generation of organoid-containing microtissues for standard phenotypic bioassays and image-based readings. To achieve this, we developed the Scaffold-supported Platform for Organoid-based Tissues (SPOT) platform. SPOT is a 3D gel-embedded in vitro platform that can be produced in a 96- or 384-well plate format and enables the generation of flat, thin and dimensionally-defined microgels. SPOT has high potential for adoption due to its reproducible manufacturing methodology, compatibility with existing instrumentation, and reduced within-sample and between-sample variation, which can pose challenges to both data analysis and interpretation. Using SPOT we generate cultures from patient derived pancreatic ductal adenocarcinoma organoids and assess the cellular response to standard-of-care chemotherapeutic compounds, demonstrating our platform’s usability for drug screening. We envision 96/384-SPOT will provide a useful tool to assess drug sensitivity of patient-derived organoids and easily integrate into the drug discovery pipeline.